Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma.

about

Potential approaches to the treatment of Ewing's sarcoma Preclinical Biodistribution and Safety Evaluation of a pbi-shRNA STMN1 Lipoplex after Subcutaneous Delivery.

P2860

Q28072744-6446C840-11DB-4BC2-952F-D546958FB0CE Q39213655-8E8078A1-13FE-47A3-945C-AF3D2C97755B

P2860

Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma.

Item

http://www.wikidata.org/entity/Q37256170

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Preclinical Justification of p ...... Treatment for Ewing's Sarcoma.

@en

Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex

@nl

type

Item

label

Preclinical Justification of p ...... Treatment for Ewing's Sarcoma.

@en

Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex

@nl

prefLabel

Preclinical Justification of p ...... Treatment for Ewing's Sarcoma.

@en

Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex

@nl

P1476

Preclinical Justification of p ...... Treatment for Ewing's Sarcoma.

@en

P2093

Christopher Jay

http://www.w3.org/2001/XMLSchema#string

Donald D Rao

http://www.w3.org/2001/XMLSchema#string

Hilary Eysenbach

http://www.w3.org/2001/XMLSchema#string

John Nemunaitis

http://www.w3.org/2001/XMLSchema#string

Maurizio Ghisoli

http://www.w3.org/2001/XMLSchema#string

Neil Senzer

http://www.w3.org/2001/XMLSchema#string

Padmasini Kumar

http://www.w3.org/2001/XMLSchema#string

Xiuquan Luo

http://www.w3.org/2001/XMLSchema#string

Zhaohui Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancer

CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis

Improving Outcomes After Relapse in Ewing's Sarcoma: Analysis of 114 Patients From a Single Institution

Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes

Ewing's sarcoma family of tumors: current management

Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma

Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans

Preclinical assessment of wt GNE gene plasmid for management of hereditary inclusion body myopathy 2 (HIBM2)

Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data.

Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma.

P304

1412-1422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2016.93

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27166877

http://www.w3.org/2001/XMLSchema#string

P932

5023384

http://www.w3.org/2001/XMLSchema#string

Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma.

about

P2860

P2860

Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932